Global Antiemetic Drugs Market Insights and Forecast to 2026

    • ID: AR2947046
    • 30 July, 2020
    • Other
    • Region: Global
    • 146 Pages
    • QYResearch

    1 Study Coverage

    • 1.1 Antiemetic Drugs Product Introduction
    • 1.2 Market Segments
    • 1.3 Key Antiemetic Drugs Manufacturers Covered: Ranking by Revenue
    • 1.4 Market by Type
      • 1.4.1 Global Antiemetic Drugs Market Size Growth Rate by Type
      • 1.4.2 Dopamine Antagonist
      • 1.4.3 5-HT-3 Receptor Antagonist
      • 1.4.4 NK1 Receptor Antagonist
      • 1.4.5 Cannabinoid Receptor Antagonist
    • 1.5 Market by Application
      • 1.5.1 Global Antiemetic Drugs Market Size Growth Rate by Application
      • 1.5.2 Chemotherapy
      • 1.5.3 Gastroenteritis
      • 1.5.4 Surgery
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Antiemetic Drugs Market Size, Estimates and Forecasts
      • 2.1.1 Global Antiemetic Drugs Revenue 2015-2026
      • 2.1.2 Global Antiemetic Drugs Sales 2015-2026
    • 2.2 Global Antiemetic Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
      • 2.2.1 Global Antiemetic Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
      • 2.2.2 Global Antiemetic Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020

    3 Global Antiemetic Drugs Competitor Landscape by Players

    • 3.1 Antiemetic Drugs Sales by Manufacturers
      • 3.1.1 Antiemetic Drugs Sales by Manufacturers (2015-2020)
      • 3.1.2 Antiemetic Drugs Sales Market Share by Manufacturers (2015-2020)
    • 3.2 Antiemetic Drugs Revenue by Manufacturers
      • 3.2.1 Antiemetic Drugs Revenue by Manufacturers (2015-2020)
      • 3.2.2 Antiemetic Drugs Revenue Share by Manufacturers (2015-2020)
      • 3.2.3 Global Antiemetic Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
      • 3.2.4 Global Top 10 and Top 5 Companies by Antiemetic Drugs Revenue in 2019
      • 3.2.5 Global Antiemetic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.3 Antiemetic Drugs Price by Manufacturers
    • 3.4 Antiemetic Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Antiemetic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Antiemetic Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Antiemetic Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type (2015-2026)

    • 4.1 Global Antiemetic Drugs Market Size by Type (2015-2020)
      • 4.1.1 Global Antiemetic Drugs Sales by Type (2015-2020)
      • 4.1.2 Global Antiemetic Drugs Revenue by Type (2015-2020)
      • 4.1.3 Antiemetic Drugs Average Selling Price (ASP) by Type (2015-2026)
    • 4.2 Global Antiemetic Drugs Market Size Forecast by Type (2021-2026)
      • 4.2.1 Global Antiemetic Drugs Sales Forecast by Type (2021-2026)
      • 4.2.2 Global Antiemetic Drugs Revenue Forecast by Type (2021-2026)
      • 4.2.3 Antiemetic Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
    • 4.3 Global Antiemetic Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Market Size by Application (2015-2026)

    • 5.1 Global Antiemetic Drugs Market Size by Application (2015-2020)
      • 5.1.1 Global Antiemetic Drugs Sales by Application (2015-2020)
      • 5.1.2 Global Antiemetic Drugs Revenue by Application (2015-2020)
      • 5.1.3 Antiemetic Drugs Price by Application (2015-2020)
    • 5.2 Antiemetic Drugs Market Size Forecast by Application (2021-2026)
      • 5.2.1 Global Antiemetic Drugs Sales Forecast by Application (2021-2026)
      • 5.2.2 Global Antiemetic Drugs Revenue Forecast by Application (2021-2026)
      • 5.2.3 Global Antiemetic Drugs Price Forecast by Application (2021-2026)

    6 North America

    • 6.1 North America Antiemetic Drugs by Country
      • 6.1.1 North America Antiemetic Drugs Sales by Country
      • 6.1.2 North America Antiemetic Drugs Revenue by Country
      • 6.1.3 U.S.
      • 6.1.4 Canada
    • 6.2 North America Antiemetic Drugs Market Facts & Figures by Type
    • 6.3 North America Antiemetic Drugs Market Facts & Figures by Application

    7 Europe

    • 7.1 Europe Antiemetic Drugs by Country
      • 7.1.1 Europe Antiemetic Drugs Sales by Country
      • 7.1.2 Europe Antiemetic Drugs Revenue by Country
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 U.K.
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Antiemetic Drugs Market Facts & Figures by Type
    • 7.3 Europe Antiemetic Drugs Market Facts & Figures by Application

    8 Asia Pacific

    • 8.1 Asia Pacific Antiemetic Drugs by Region
      • 8.1.1 Asia Pacific Antiemetic Drugs Sales by Region
      • 8.1.2 Asia Pacific Antiemetic Drugs Revenue by Region
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 South Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Taiwan
      • 8.1.9 Indonesia
      • 8.1.10 Thailand
      • 8.1.11 Malaysia
      • 8.1.12 Philippines
      • 8.1.13 Vietnam
    • 8.2 Asia Pacific Antiemetic Drugs Market Facts & Figures by Type
    • 8.3 Asia Pacific Antiemetic Drugs Market Facts & Figures by Application

    9 Latin America

    • 9.1 Latin America Antiemetic Drugs by Country
      • 9.1.1 Latin America Antiemetic Drugs Sales by Country
      • 9.1.2 Latin America Antiemetic Drugs Revenue by Country
      • 9.1.3 Mexico
      • 9.1.4 Brazil
      • 9.1.5 Argentina
    • 9.2 Central & South America Antiemetic Drugs Market Facts & Figures by Type
    • 9.3 Central & South America Antiemetic Drugs Market Facts & Figures by Application

    10 Middle East and Africa

    • 10.1 Middle East and Africa Antiemetic Drugs by Country
      • 10.1.1 Middle East and Africa Antiemetic Drugs Sales by Country
      • 10.1.2 Middle East and Africa Antiemetic Drugs Revenue by Country
      • 10.1.3 Turkey
      • 10.1.4 Saudi Arabia
      • 10.1.5 U.A.E
    • 10.2 Middle East and Africa Antiemetic Drugs Market Facts & Figures by Type
    • 10.3 Middle East and Africa Antiemetic Drugs Market Facts & Figures by Application

    11 Company Profiles

    • 11.1 GlaxoSmithKline
      • 11.1.1 GlaxoSmithKline Corporation Information
      • 11.1.2 GlaxoSmithKline Description and Business Overview
      • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
      • 11.1.4 GlaxoSmithKline Antiemetic Drugs Products Offered
      • 11.1.5 GlaxoSmithKline Related Developments
    • 11.2 Johnson & Johnson
      • 11.2.1 Johnson & Johnson Corporation Information
      • 11.2.2 Johnson & Johnson Description and Business Overview
      • 11.2.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
      • 11.2.4 Johnson & Johnson Antiemetic Drugs Products Offered
      • 11.2.5 Johnson & Johnson Related Developments
    • 11.3 Pfizer
      • 11.3.1 Pfizer Corporation Information
      • 11.3.2 Pfizer Description and Business Overview
      • 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
      • 11.3.4 Pfizer Antiemetic Drugs Products Offered
      • 11.3.5 Pfizer Related Developments
    • 11.4 Sanofi
      • 11.4.1 Sanofi Corporation Information
      • 11.4.2 Sanofi Description and Business Overview
      • 11.4.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
      • 11.4.4 Sanofi Antiemetic Drugs Products Offered
      • 11.4.5 Sanofi Related Developments
    • 11.5 Abbott
      • 11.5.1 Abbott Corporation Information
      • 11.5.2 Abbott Description and Business Overview
      • 11.5.3 Abbott Sales, Revenue and Gross Margin (2015-2020)
      • 11.5.4 Abbott Antiemetic Drugs Products Offered
      • 11.5.5 Abbott Related Developments
    • 11.6 Bristol-Myers Squibb
      • 11.6.1 Bristol-Myers Squibb Corporation Information
      • 11.6.2 Bristol-Myers Squibb Description and Business Overview
      • 11.6.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
      • 11.6.4 Bristol-Myers Squibb Antiemetic Drugs Products Offered
      • 11.6.5 Bristol-Myers Squibb Related Developments
    • 11.7 Cipla
      • 11.7.1 Cipla Corporation Information
      • 11.7.2 Cipla Description and Business Overview
      • 11.7.3 Cipla Sales, Revenue and Gross Margin (2015-2020)
      • 11.7.4 Cipla Antiemetic Drugs Products Offered
      • 11.7.5 Cipla Related Developments
    • 11.8 Eisai
      • 11.8.1 Eisai Corporation Information
      • 11.8.2 Eisai Description and Business Overview
      • 11.8.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
      • 11.8.4 Eisai Antiemetic Drugs Products Offered
      • 11.8.5 Eisai Related Developments
    • 11.9 Eli Lilly
      • 11.9.1 Eli Lilly Corporation Information
      • 11.9.2 Eli Lilly Description and Business Overview
      • 11.9.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
      • 11.9.4 Eli Lilly Antiemetic Drugs Products Offered
      • 11.9.5 Eli Lilly Related Developments
    • 11.10 Glenmark
      • 11.10.1 Glenmark Corporation Information
      • 11.10.2 Glenmark Description and Business Overview
      • 11.10.3 Glenmark Sales, Revenue and Gross Margin (2015-2020)
      • 11.10.4 Glenmark Antiemetic Drugs Products Offered
      • 11.10.5 Glenmark Related Developments
    • 11.1 GlaxoSmithKline
      • 11.1.1 GlaxoSmithKline Corporation Information
      • 11.1.2 GlaxoSmithKline Description and Business Overview
      • 11.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
      • 11.1.4 GlaxoSmithKline Antiemetic Drugs Products Offered
      • 11.1.5 GlaxoSmithKline Related Developments
    • 11.12 Heron Therapeutics
      • 11.12.1 Heron Therapeutics Corporation Information
      • 11.12.2 Heron Therapeutics Description and Business Overview
      • 11.12.3 Heron Therapeutics Sales, Revenue and Gross Margin (2015-2020)
      • 11.12.4 Heron Therapeutics Products Offered
      • 11.12.5 Heron Therapeutics Related Developments
    • 11.13 IPCA Laboratories
      • 11.13.1 IPCA Laboratories Corporation Information
      • 11.13.2 IPCA Laboratories Description and Business Overview
      • 11.13.3 IPCA Laboratories Sales, Revenue and Gross Margin (2015-2020)
      • 11.13.4 IPCA Laboratories Products Offered
      • 11.13.5 IPCA Laboratories Related Developments
    • 11.14 Lupin
      • 11.14.1 Lupin Corporation Information
      • 11.14.2 Lupin Description and Business Overview
      • 11.14.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
      • 11.14.4 Lupin Products Offered
      • 11.14.5 Lupin Related Developments
    • 11.15 Merck
      • 11.15.1 Merck Corporation Information
      • 11.15.2 Merck Description and Business Overview
      • 11.15.3 Merck Sales, Revenue and Gross Margin (2015-2020)
      • 11.15.4 Merck Products Offered
      • 11.15.5 Merck Related Developments
    • 11.16 Novartis
      • 11.16.1 Novartis Corporation Information
      • 11.16.2 Novartis Description and Business Overview
      • 11.16.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
      • 11.16.4 Novartis Products Offered
      • 11.16.5 Novartis Related Developments
    • 11.17 RedHill
      • 11.17.1 RedHill Corporation Information
      • 11.17.2 RedHill Description and Business Overview
      • 11.17.3 RedHill Sales, Revenue and Gross Margin (2015-2020)
      • 11.17.4 RedHill Products Offered
      • 11.17.5 RedHill Related Developments
    • 11.18 Sun Pharmaceutical Industries
      • 11.18.1 Sun Pharmaceutical Industries Corporation Information
      • 11.18.2 Sun Pharmaceutical Industries Description and Business Overview
      • 11.18.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
      • 11.18.4 Sun Pharmaceutical Industries Products Offered
      • 11.18.5 Sun Pharmaceutical Industries Related Developments
    • 11.19 Takeda Pharmaceutical
      • 11.19.1 Takeda Pharmaceutical Corporation Information
      • 11.19.2 Takeda Pharmaceutical Description and Business Overview
      • 11.19.3 Takeda Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
      • 11.19.4 Takeda Pharmaceutical Products Offered
      • 11.19.5 Takeda Pharmaceutical Related Developments

    12 Future Forecast by Regions (Countries) (2021-2026)

    • 12.1 Antiemetic Drugs Market Estimates and Projections by Region
      • 12.1.1 Global Antiemetic Drugs Sales Forecast by Regions 2021-2026
      • 12.1.2 Global Antiemetic Drugs Revenue Forecast by Regions 2021-2026
    • 12.2 North America Antiemetic Drugs Market Size Forecast (2021-2026)
      • 12.2.1 North America: Antiemetic Drugs Sales Forecast (2021-2026)
      • 12.2.2 North America: Antiemetic Drugs Revenue Forecast (2021-2026)
      • 12.2.3 North America: Antiemetic Drugs Market Size Forecast by Country (2021-2026)
    • 12.3 Europe Antiemetic Drugs Market Size Forecast (2021-2026)
      • 12.3.1 Europe: Antiemetic Drugs Sales Forecast (2021-2026)
      • 12.3.2 Europe: Antiemetic Drugs Revenue Forecast (2021-2026)
      • 12.3.3 Europe: Antiemetic Drugs Market Size Forecast by Country (2021-2026)
    • 12.4 Asia Pacific Antiemetic Drugs Market Size Forecast (2021-2026)
      • 12.4.1 Asia Pacific: Antiemetic Drugs Sales Forecast (2021-2026)
      • 12.4.2 Asia Pacific: Antiemetic Drugs Revenue Forecast (2021-2026)
      • 12.4.3 Asia Pacific: Antiemetic Drugs Market Size Forecast by Region (2021-2026)
    • 12.5 Latin America Antiemetic Drugs Market Size Forecast (2021-2026)
      • 12.5.1 Latin America: Antiemetic Drugs Sales Forecast (2021-2026)
      • 12.5.2 Latin America: Antiemetic Drugs Revenue Forecast (2021-2026)
      • 12.5.3 Latin America: Antiemetic Drugs Market Size Forecast by Country (2021-2026)
    • 12.6 Middle East and Africa Antiemetic Drugs Market Size Forecast (2021-2026)
      • 12.6.1 Middle East and Africa: Antiemetic Drugs Sales Forecast (2021-2026)
      • 12.6.2 Middle East and Africa: Antiemetic Drugs Revenue Forecast (2021-2026)
      • 12.6.3 Middle East and Africa: Antiemetic Drugs Market Size Forecast by Country (2021-2026)

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Porter's Five Forces Analysis
    • 13.5 Primary Interviews with Key Antiemetic Drugs Players (Opinion Leaders)

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Antiemetic Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      Antiemetic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiemetic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

      Segment by Type, the Antiemetic Drugs market is segmented into
      Dopamine Antagonist
      5-HT-3 Receptor Antagonist
      NK1 Receptor Antagonist
      Cannabinoid Receptor Antagonist

      Segment by Application, the Antiemetic Drugs market is segmented into
      Chemotherapy
      Gastroenteritis
      Surgery

      Regional and Country-level Analysis
      The Antiemetic Drugs market is analysed and market size information is provided by regions (countries).
      The key regions covered in the Antiemetic Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
      The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
      Competitive Landscape and Antiemetic Drugs Market Share Analysis
      Antiemetic Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Antiemetic Drugs business, the date to enter into the Antiemetic Drugs market, Antiemetic Drugs product introduction, recent developments, etc.

      The major vendors covered:
      GlaxoSmithKline
      Johnson & Johnson
      Pfizer
      Sanofi
      Abbott
      Bristol-Myers Squibb
      Cipla
      Eisai
      Eli Lilly
      Glenmark
      Helsinn Healthcare
      Heron Therapeutics
      IPCA Laboratories
      Lupin
      Merck
      Novartis
      RedHill
      Sun Pharmaceutical Industries
      Takeda Pharmaceutical



      Summary:
      Antiemetic Drugs Market Research Report is about Antiemetic Drugs Industry study. Get complete Antiemetic Drugs market research report published after Market Study, Industrial Analysis with Trends & Statistics. Antiemetic Drugs Market Report is a syndicated report for Investors and Manufacturer to understand Market Demand, Growth, trends and Factor Influencing market in upcoming years.



      REPORT YOU MIGHT BE INTERESTED

      $3,900.00
      $3,900.00
      $3,900.00
      $3,900.00
      $3,900.00